Shai Efrati, MD
Sagol Center for Hyperbaric Medicine, Tel Aviv · Israel
Neurological HBOT — TBI, stroke, long COVID, fibromyalgia, anti-aging
Director of the Sagol Center and the most-published modern HBOT researcher. Developed the 2.0 ATA / 40–60 session protocol used across neurological indications. Co-founded Aviv Clinics for US clinical application.
Key works:
- Boussi-Gross 2013 (TBI RCT, PLOS ONE)
- Efrati 2013 (stroke, PLOS ONE)
- Efrati 2015 (fibromyalgia, PLOS ONE)
- Hachmo 2020 (telomere length, Aging)
Latest publications on PubMed →
Paul Harch, MD
LSU Health New Orleans · US
TBI, PTSD, veteran populations, chronic neurological conditions
Pioneered off-label HBOT for post-concussion syndrome and PTSD in veterans. Harch 2017 trial supports state-level TBI/PTSD programmes.
Key works:
- Harch 2017 (TBI/PTSD, Med Gas Res)
- Harch 2012 (TBI case series, J Neurotrauma)
Latest publications on PubMed →
Lindell Weaver, MD
Intermountain LDS Hospital, Salt Lake City · US
Carbon monoxide poisoning, emergency HBOT
Lead author of the Weaver 2002 NEJM RCT establishing the three-session HBOT protocol as standard of care for acute CO poisoning.
Key works:
- Weaver 2002 (CO poisoning, NEJM)
- Weaver 2014 (CO 6-year follow-up, UHM)
Latest publications on PubMed →
Richard Moon, MD
Duke Center for Hyperbaric Medicine · US
Diving medicine, decompression sickness, emergency HBOT
Long-standing director of Duke hyperbaric programme. Reference authority on diving medicine and recompression treatment.
Key works:
- Moon 2014 (DCS treatment review)
- Numerous diving medicine clinical references
Latest publications on PubMed →
Stephen Thom, MD, PhD
University of Maryland (previously Penn) · US
HBOT mechanisms, stem cell mobilisation, NO signalling
Leading HBOT basic-science researcher. Thom 2011 Plast Reconstr Surg remains the most-cited HBOT mechanism synthesis.
Key works:
- Thom 2011 (HBOT mechanisms, Plast Reconstr Surg)
- Thom 2006 (stem cell mobilisation)
Latest publications on PubMed →
Michael Bennett, MBBS, MD
University of New South Wales · Australia
Cochrane systematic reviews, evidence synthesis
Lead author of the Cochrane HBOT reviews — radiation injury, hearing loss, necrotising fasciitis, MS, burns, thermal. The reference voice on HBOT evidence synthesis.
Key works:
- Bennett 2016 (radiation injury Cochrane)
- Bennett 2012 (SSNHL Cochrane)
- Bennett 2011 (MS Cochrane)
- Levett/Bennett 2015 (necrotising fasciitis)
Latest publications on PubMed →
Magnus Löndahl, MD, PhD
Lund University · Sweden
Diabetic foot ulcers, wound HBOT
Löndahl 2010 RCT in Diabetes Care — strongest evidence base for HBOT in Wagner Grade 3+ diabetic foot ulcers.
Key works:
- Löndahl 2010 (diabetic foot ulcers, Diabetes Care)
Latest publications on PubMed →
Robert E. Marx, DDS
University of Miami (emeritus) · US
Osteoradionecrosis, oral-maxillofacial surgery
Marx 1985 RCT established the pre-/post-extraction HBOT protocol for ORN prevention in irradiated jaws — still the clinical standard.
Key works:
- Marx 1985 (osteoradionecrosis prevention, JADA)
Latest publications on PubMed →
Gaylan Rockswold, MD, PhD
Hennepin County Medical Center, Minneapolis · US
Acute severe TBI, cerebral metabolism
Rockswold trials studied HBOT in acute severe TBI (ICP, cerebral metabolism endpoints) — distinct from the Efrati chronic-TBI research.
Key works:
- Rockswold 2013 (acute severe TBI, J Neurosurg)
Latest publications on PubMed →
Daniel Mathieu, MD
ECHM (European Committee for Hyperbaric Medicine) · France
European consensus guidelines, clinical HBOT policy
Co-author of the European Consensus Conference on Hyperbaric Medicine — European counterpart to the UHMS indication list.
Key works:
- Mathieu 2017 (Tenth European Consensus Conference, DHM)
Latest publications on PubMed →
Enrico Camporesi, MD
University of South Florida · US
Avascular necrosis, chamber physiology
Long-standing contributor to clinical and physiological HBOT research; Camporesi 2010 supports UHMS approval for femoral head AVN.
Key works:
- Camporesi 2010 (femoral head AVN, J Arthroplasty)
Latest publications on PubMed →
Daniel Rossignol, MD
International Child Development Resource Center · US
HBOT in autism spectrum disorder
Rossignol 2009 BMC Pediatrics RCT — the most-cited (and contested) HBOT trial in autism. 1.3 ATA protocol, methodological debate ongoing.
Key works:
- Rossignol 2009 (autism RCT, BMC Pediatrics)
Latest publications on PubMed →